Barbara C Merk et al. demonstrated in 2011 [29] that STAT6 acts to enhance cell proliferation and invasion in glioblastoma, which may explain why up-regulation of STAT6 correlates with shorter survival times in glioma patients. Here, STAT6 is linked to glioblastoma.